# US 2019/0169571 A1 · Method for producing cultivated epithelial cell sheet

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0169571 A1
- Document ID: US20190169571A1
- Status: Published application
- Kind: A1
- Application number: 16/095,173
- Filed: 2017-04-19
- Published: 2019-06-06
- Earliest claimed: 2016-04-20
- Assignees: Kyoto Prefectural Public University Corporation
- Applicants: Kyoto Prefectural Public University Corporation
- Inventors: Takahiro NAKAMURA; Shigeru KINOSHITA; Seiichi YOKOO; Satoru YAMAGAMI
- Web page: https://patentgrep.com/patent/US20190169571A1

## CPC

- C12N 5/0632: {Cells of the oral mucosa}
- A61K 35/38: Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
- A61L 27/3604: {characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel}
- A61L 27/3641: {characterised by the site of application in the body (materials for artificial blood vessels A61L27/507; materials for use in artificial skin A61L27/60)}
- A61P 27/02: Ophthalmic agents
- C12N 5/0625: {Epidermal cells, skin cells; Cells of the oral mucosa}
- A61K 35/36: Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells (islets of Langerhans A61K35/39)
- A61L 27/00: Materials for {grafts or} prostheses or for coating {grafts or} prostheses (dental prostheses A61C13/00; shape or structure of prostheses A61F2/00; use of preparations for artificial teeth A61K6/80; artificial kidneys A61M1/14)
- C12N 2500/00: Specific components of cell culture medium
- C12N 2500/30: Organic components
- C12N 2500/34: Sugars
- C12N 2500/35: Polyols, e.g. glycerin, inositol
- C12N 2500/90: Serum-free medium, which may still contain naturally-sourced components
- C12N 2501/11: Epidermal growth factor [EGF]
- C12N 2501/117: Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
- C12N 2501/39: Steroid hormones
- C12N 2501/727: Kinases (EC 2.7.)
- C12N 2501/90: Polysaccharides
- C12N 2533/92: Amnion; Decellularised dermis or mucosa
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A method for producing an epithelial cell sheet, comprising culturing cells derived from oral mucosal epithelial cells on a substrate in a serum-free medium, wherein the serum-free medium comprises (i) EGF protein or KGF protein, (ii) B-27 supplement, and (iii) a ROCK inhibitor.

## Claims

### Claim at position 1

1-4. (canceled)

### Claim 5

A method for producing an epithelial cell sheet in which cells that express an epithelial stem cell marker, a proliferating cell marker, and corneal epithelial cell marker keratin 12 and maintain a property as stem cells are present, the method comprising culturing cells derived from oral mucosal epithelial cells on a substrate in a serum-free medium,
wherein the serum-free medium comprises
(i) EGF protein or KGF protein,
(ii) B-27 supplement,
(iii) a ROCK inhibitor, and
(v) one or more catechin.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the medium further comprises at least one member selected from the group consisting of
(iv) polysaccharides, and
(vi) corticoids.

### Claim 7 (depends on 5)

An epithelial cell sheet obtained by the method according to claim 5, wherein cells that express an epithelial stem cell marker, a proliferating cell marker, and corneal epithelial cell marker keratin 12 and maintain a property as stem cells are present.

### Claim 8

A serum-free medium for producing an epithelial cell sheet in which cells that express an epithelial stem cell marker, a proliferating cell marker, and corneal epithelial cell marker keratin 12 and maintain a property as stem cells are present, using cells derived from oral mucosal epithelial cells, the medium comprising
(i) EGF protein or KGF protein,
(ii) B-27 supplement, and
(iii) a ROCK inhibitor.

### Claim 9 (depends on 6)

An epithelial cell sheet obtained by the method according to claim 6, wherein cells that express an epithelial stem cell marker, a proliferating cell marker, and corneal epithelial cell marker keratin 12 and maintain a property as stem cells are present.
